These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6683289)

  • 1. Binding capacity of testosterone-estradiol-binding globulin (TeBG), total and calculated unbound concentrations of testosterone in patients with carcinoma of the prostate treated with orchidectomy or estrogens.
    Damber JE; Bergman B; Södergård R; Tomić R
    J Endocrinol Invest; 1983 Apr; 6(2):91-4. PubMed ID: 6683289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of testosterone, sex hormone binding globulin, and calculated free testosterone to subsequent clinical progress in patients with carcinoma of the prostate treated with bilateral orchidectomy or estrogens.
    Levell MJ; Siddall JK; Rowe E; Glashan RW; Robinson MR; Pidcock NB
    Prostate; 1987; 11(1):17-21. PubMed ID: 3658825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone-estradiol-binding globulin, unbound and total estradiol and testosterone, and total progesterone during the menstrual cycle in women with epilepsy taking antiepileptic drugs.
    Bäckström CT; Södergård R
    J Endocrinol Invest; 1979; 2(4):359-66. PubMed ID: 575378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changes in the binding capacity of testosterone-oestradiol binding globulin (TeBG) following castration and DES-D administration in patients with prostatic carcinoma.
    Usui T; Sagami K; Kitano T; Nihira H; Miyachi Y
    Urol Res; 1982; 10(3):119-22. PubMed ID: 6890254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.
    Varenhorst E; Wallentin L; Carlström K
    Scand J Urol Nephrol; 1982; 16(1):31-6. PubMed ID: 6211762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of orchidectomy performed after cessation of estrogen therapy on serum testosterone concentrations in patients with prostatic carcinoma.
    Tomić R; Damber JE
    Urol Int; 1987; 42(6):441-4. PubMed ID: 3129850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.
    Södergård R; Bäckström T; Shanbhag V; Carstensen H
    J Steroid Biochem; 1982 Jun; 16(6):801-10. PubMed ID: 7202083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma.
    Leinonen P; Hammond GL; Lukkarinen O; Vihko R
    Invest Urol; 1979 Jul; 17(1):24-7. PubMed ID: 571863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of total and subcapsular orchidectomy on serum concentrations of testosterone and pituitary hormones in patients with carcinoma of the prostate.
    Bergman B; Damber JE; Tomić R
    Urol Int; 1982; 37(2):139-44. PubMed ID: 6810527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in saliva and prostatic dihydrotestosterone levels.
    Boccon-Gibod L; Laudat MH; Guiban D; Steg A
    Eur Urol; 1988; 15(1-2):99-102. PubMed ID: 3215246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total and free testosterone in plasma of hypo- and agonadal men.
    Stahl F; Dörner G; Knappe G; Schnorr D
    Endokrinologie; 1975 Nov; 66(2):152-7. PubMed ID: 1227846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
    Tomić R; Ljungberg B; Damber JE
    Scand J Urol Nephrol; 1988; 22(1):15-8. PubMed ID: 2968646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].
    Stahl F; Schnorr D; Rohde W; Dörner G
    Z Urol Nephrol; 1987 Mar; 80(3):135-8. PubMed ID: 3604472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in the saliva.
    Boccon-Gibod L; Laudat MH; Guiban D; Steg A
    Prog Clin Biol Res; 1987; 243A():45-53. PubMed ID: 3659006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interrelation of sex hormone-binding globulin and the androgen-estrogen balance in patients with hypercorticism].
    Bezverkhaia TP; Varga SV; Verkhogliadova LM
    Probl Endokrinol (Mosk); 1986; 32(5):48-51. PubMed ID: 3786304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influx of testosterone-binding globulin (TeBG) and TeBG-bound sex steroid hormones into rat testis and prostate.
    Sakiyama R; Pardridge WM; Musto NA
    J Clin Endocrinol Metab; 1988 Jul; 67(1):98-103. PubMed ID: 3379140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of orchidectomy or oestrogen treatment on serum levels of pregnancy associated alpha 2-glycoprotein and sex hormone binding globulin in patients with prostatic cancer.
    Carlström K; Eriksson A; Gustafsson SA; Henriksson P; Pousette A; Stege R; von Schoultz B
    Int J Androl; 1985 Feb; 8(1):21-7. PubMed ID: 3922901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactinomas, testosterone-binding globulin, and androgen metabolism.
    Vermeulen A; Andó S; Verdonck L
    J Clin Endocrinol Metab; 1982 Feb; 54(2):409-12. PubMed ID: 7198651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of ethinyl estradiol sulfonate in conservative therapy of prostate cancer].
    Guddat HM; Schnorr D; Dörner G; Stahl F; Rhode W
    Z Urol Nephrol; 1987 Mar; 80(3):125-33. PubMed ID: 3604471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.